283 related articles for article (PubMed ID: 29961281)
1. [Clinical significance of centralized surveillance of hydatidiform mole].
Jiao LZ; Wang YP; Jiang JY; Zhang WQ; Wang XY; Zhu CG; Zhang YW
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):390-395. PubMed ID: 29961281
[No Abstract] [Full Text] [Related]
2. Centralized surveillance of hydatidiform mole: 7-year experience from a regional hospital in China.
Jiao L; Wang Y; Jiang J; Wang X; Zhang W; Zhu C; Xiang Y
Int J Gynecol Cancer; 2022 Feb; 32(2):147-152. PubMed ID: 34799419
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and diagnosis of early hydatidiform mole].
Jiao LZ; You SY; Wang YP; Zhu CG; Jiang JY
Zhonghua Fu Chan Ke Za Zhi; 2019 Nov; 54(11):756-762. PubMed ID: 31752459
[No Abstract] [Full Text] [Related]
4. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
[TBL] [Abstract][Full Text] [Related]
6. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
Stone M; Bagshawe KD
Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles.
Eagles N; Sebire NJ; Short D; Savage PM; Seckl MJ; Fisher RA
Hum Reprod; 2015 Sep; 30(9):2055-63. PubMed ID: 26202916
[TBL] [Abstract][Full Text] [Related]
8. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome.
Hancock BW; Nazir K; Everard JE
J Reprod Med; 2006 Oct; 51(10):764-6. PubMed ID: 17086803
[TBL] [Abstract][Full Text] [Related]
9. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
10. [Hydatidiform mole and malignant trophoblastic tumors initiated by hydatidiform mole. Standards and innovation of diagnosis and treatment].
Tsip NP
Vopr Onkol; 2014; 60(3):396-401. PubMed ID: 25033699
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study.
Zhao P; Chen Q; Lu W
BMC Cancer; 2017 Nov; 17(1):733. PubMed ID: 29121880
[TBL] [Abstract][Full Text] [Related]
12. The management of hydatidiform mole with lung nodule: a retrospective analysis in 53 patients.
Li X; Xu Y; Liu Y; Cheng X; Wang X; Lu W; Xie X
J Gynecol Oncol; 2019 Mar; 30(2):e16. PubMed ID: 30740949
[TBL] [Abstract][Full Text] [Related]
13. A clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990): histologic grade lacks prognostic significance.
Genest DR; Laborde O; Berkowitz RS; Goldstein DP; Bernstein MR; Lage J
Obstet Gynecol; 1991 Sep; 78(3 Pt 1):402-9. PubMed ID: 1876374
[TBL] [Abstract][Full Text] [Related]
14. Predictors of persistent disease in women with complete hydatidiform mole.
Ayhan A; Tuncer ZS; Halilzade H; Küçükali T
J Reprod Med; 1996 Aug; 41(8):591-4. PubMed ID: 8866387
[TBL] [Abstract][Full Text] [Related]
15. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of hydatidiform mole and choriocarcinoma.
Bracken MB; Brinton LA; Hayashi K
Epidemiol Rev; 1984; 6():52-75. PubMed ID: 6386504
[TBL] [Abstract][Full Text] [Related]
17. [Effects of prophylactic chemotherapy on outcomes and prognosis of patients older than 40 years with invasive mole].
Jiang SY; Li L; Zhao J; Xiang Y; Wan XR; Feng FZ; Ren T; Yang JJ
Zhonghua Fu Chan Ke Za Zhi; 2017 Jun; 52(6):398-402. PubMed ID: 28647963
[No Abstract] [Full Text] [Related]
18. [Risk factors for gestational trophoblastic tumors following complete hydatidiform mole].
Grzybowski W; Płoszyński A; Mielnik J; Adamcio-Deptulska M; Preis K; Wojciechowska D
Ginekol Pol; 2002 Nov; 73(11):1003-10. PubMed ID: 12722390
[TBL] [Abstract][Full Text] [Related]
19. Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life.
Bandy LC; Clarke-Pearson DL; Hammond CB
Obstet Gynecol; 1984 Sep; 64(3):395-9. PubMed ID: 6087230
[TBL] [Abstract][Full Text] [Related]
20. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
